Chapter/Section Purchase

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Anti-Platelet Drugs
1.2.3 Dual Antiplatelet Therapy Drugs
1.2.4 Others
1.3 Market by Application
1.3.1 Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Peripheral Arterial Disease (PAD) Therapeutics Market Perspective (2017-2028)
2.2 Peripheral Arterial Disease (PAD) Therapeutics Growth Trends by Region
2.2.1 Peripheral Arterial Disease (PAD) Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Peripheral Arterial Disease (PAD) Therapeutics Historic Market Size by Region (2017-2022)
2.2.3 Peripheral Arterial Disease (PAD) Therapeutics Forecasted Market Size by Region (2023-2028)
2.3 Peripheral Arterial Disease (PAD) Therapeutics Market Dynamics
2.3.1 Peripheral Arterial Disease (PAD) Therapeutics Industry Trends
2.3.2 Peripheral Arterial Disease (PAD) Therapeutics Market Drivers
2.3.3 Peripheral Arterial Disease (PAD) Therapeutics Market Challenges
2.3.4 Peripheral Arterial Disease (PAD) Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Peripheral Arterial Disease (PAD) Therapeutics Players by Revenue
3.1.1 Global Top Peripheral Arterial Disease (PAD) Therapeutics Players by Revenue (2017-2022)
3.1.2 Global Peripheral Arterial Disease (PAD) Therapeutics Revenue Market Share by Players (2017-2022)
3.2 Global Peripheral Arterial Disease (PAD) Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Peripheral Arterial Disease (PAD) Therapeutics Revenue
3.4 Global Peripheral Arterial Disease (PAD) Therapeutics Market Concentration Ratio
3.4.1 Global Peripheral Arterial Disease (PAD) Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Peripheral Arterial Disease (PAD) Therapeutics Revenue in 2021
3.5 Peripheral Arterial Disease (PAD) Therapeutics Key Players Head office and Area Served
3.6 Key Players Peripheral Arterial Disease (PAD) Therapeutics Product Solution and Service
3.7 Date of Enter into Peripheral Arterial Disease (PAD) Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Peripheral Arterial Disease (PAD) Therapeutics Breakdown Data by Type
4.1 Global Peripheral Arterial Disease (PAD) Therapeutics Historic Market Size by Type (2017-2022)
4.2 Global Peripheral Arterial Disease (PAD) Therapeutics Forecasted Market Size by Type (2023-2028)
5 Peripheral Arterial Disease (PAD) Therapeutics Breakdown Data by Application
5.1 Global Peripheral Arterial Disease (PAD) Therapeutics Historic Market Size by Application (2017-2022)
5.2 Global Peripheral Arterial Disease (PAD) Therapeutics Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Peripheral Arterial Disease (PAD) Therapeutics Market Size (2017-2028)
6.2 North America Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type
6.2.1 North America Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type (2017-2022)
6.2.2 North America Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type (2023-2028)
6.2.3 North America Peripheral Arterial Disease (PAD) Therapeutics Market Share by Type (2017-2028)
6.3 North America Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application
6.3.1 North America Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application (2017-2022)
6.3.2 North America Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application (2023-2028)
6.3.3 North America Peripheral Arterial Disease (PAD) Therapeutics Market Share by Application (2017-2028)
6.4 North America Peripheral Arterial Disease (PAD) Therapeutics Market Size by Country
6.4.1 North America Peripheral Arterial Disease (PAD) Therapeutics Market Size by Country (2017-2022)
6.4.2 North America Peripheral Arterial Disease (PAD) Therapeutics Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size (2017-2028)
7.2 Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type
7.2.1 Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type (2017-2022)
7.2.2 Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type (2023-2028)
7.2.3 Europe Peripheral Arterial Disease (PAD) Therapeutics Market Share by Type (2017-2028)
7.3 Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application
7.3.1 Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application (2017-2022)
7.3.2 Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application (2023-2028)
7.3.3 Europe Peripheral Arterial Disease (PAD) Therapeutics Market Share by Application (2017-2028)
7.4 Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size by Country
7.4.1 Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size by Country (2017-2022)
7.4.2 Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Peripheral Arterial Disease (PAD) Therapeutics Market Size (2017-2028)
8.2 Asia-Pacific Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type
8.2.1 Asia-Pacific Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Peripheral Arterial Disease (PAD) Therapeutics Market Share by Type (2017-2028)
8.3 Asia-Pacific Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application
8.3.1 Asia-Pacific Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Peripheral Arterial Disease (PAD) Therapeutics Market Share by Application (2017-2028)
8.4 Asia-Pacific Peripheral Arterial Disease (PAD) Therapeutics Market Size by Region
8.4.1 Asia-Pacific Peripheral Arterial Disease (PAD) Therapeutics Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Peripheral Arterial Disease (PAD) Therapeutics Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Peripheral Arterial Disease (PAD) Therapeutics Market Size (2017-2028)
9.2 Latin America Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type
9.2.1 Latin America Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type (2017-2022)
9.2.2 Latin America Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type (2023-2028)
9.2.3 Latin America Peripheral Arterial Disease (PAD) Therapeutics Market Share by Type (2017-2028)
9.3 Latin America Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application
9.3.1 Latin America Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application (2017-2022)
9.3.2 Latin America Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application (2023-2028)
9.3.3 Latin America Peripheral Arterial Disease (PAD) Therapeutics Market Share by Application (2017-2028)
9.4 Latin America Peripheral Arterial Disease (PAD) Therapeutics Market Size by Country
9.4.1 Latin America Peripheral Arterial Disease (PAD) Therapeutics Market Size by Country (2017-2022)
9.4.2 Latin America Peripheral Arterial Disease (PAD) Therapeutics Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Peripheral Arterial Disease (PAD) Therapeutics Market Size (2017-2028)
10.2 Middle East & Africa Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type
10.2.1 Middle East & Africa Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Peripheral Arterial Disease (PAD) Therapeutics Market Share by Type (2017-2028)
10.3 Middle East & Africa Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application
10.3.1 Middle East & Africa Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Peripheral Arterial Disease (PAD) Therapeutics Market Share by Application (2017-2028)
10.4 Middle East & Africa Peripheral Arterial Disease (PAD) Therapeutics Market Size by Country
10.4.1 Middle East & Africa Peripheral Arterial Disease (PAD) Therapeutics Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Peripheral Arterial Disease (PAD) Therapeutics Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 AstraZeneca Plc. (UK)
11.1.1 AstraZeneca Plc. (UK) Company Details
11.1.2 AstraZeneca Plc. (UK) Business Overview
11.1.3 AstraZeneca Plc. (UK) Peripheral Arterial Disease (PAD) Therapeutics Introduction
11.1.4 AstraZeneca Plc. (UK) Revenue in Peripheral Arterial Disease (PAD) Therapeutics Business (2017-2022)
11.1.5 AstraZeneca Plc. (UK) Recent Developments
11.2 Bayer HealthCare Pharmaceuticals (Germany)
11.2.1 Bayer HealthCare Pharmaceuticals (Germany) Company Details
11.2.2 Bayer HealthCare Pharmaceuticals (Germany) Business Overview
11.2.3 Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Therapeutics Introduction
11.2.4 Bayer HealthCare Pharmaceuticals (Germany) Revenue in Peripheral Arterial Disease (PAD) Therapeutics Business (2017-2022)
11.2.5 Bayer HealthCare Pharmaceuticals (Germany) Recent Developments
11.3 Bristol-Myers Squibb Company (US)
11.3.1 Bristol-Myers Squibb Company (US) Company Details
11.3.2 Bristol-Myers Squibb Company (US) Business Overview
11.3.3 Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Therapeutics Introduction
11.3.4 Bristol-Myers Squibb Company (US) Revenue in Peripheral Arterial Disease (PAD) Therapeutics Business (2017-2022)
11.3.5 Bristol-Myers Squibb Company (US) Recent Developments
11.4 Merck & Co., Inc. (US)
11.4.1 Merck & Co., Inc. (US) Company Details
11.4.2 Merck & Co., Inc. (US) Business Overview
11.4.3 Merck & Co., Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Introduction
11.4.4 Merck & Co., Inc. (US) Revenue in Peripheral Arterial Disease (PAD) Therapeutics Business (2017-2022)
11.4.5 Merck & Co., Inc. (US) Recent Developments
11.5 Proteon Therapeutics, Inc. (US)
11.5.1 Proteon Therapeutics, Inc. (US) Company Details
11.5.2 Proteon Therapeutics, Inc. (US) Business Overview
11.5.3 Proteon Therapeutics, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Introduction
11.5.4 Proteon Therapeutics, Inc. (US) Revenue in Peripheral Arterial Disease (PAD) Therapeutics Business (2017-2022)
11.5.5 Proteon Therapeutics, Inc. (US) Recent Developments
11.6 Sanofi S.A. (France)
11.6.1 Sanofi S.A. (France) Company Details
11.6.2 Sanofi S.A. (France) Business Overview
11.6.3 Sanofi S.A. (France) Peripheral Arterial Disease (PAD) Therapeutics Introduction
11.6.4 Sanofi S.A. (France) Revenue in Peripheral Arterial Disease (PAD) Therapeutics Business (2017-2022)
11.6.5 Sanofi S.A. (France) Recent Developments
11.7 Symic Bio, Inc. (US)
11.7.1 Symic Bio, Inc. (US) Company Details
11.7.2 Symic Bio, Inc. (US) Business Overview
11.7.3 Symic Bio, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Introduction
11.7.4 Symic Bio, Inc. (US) Revenue in Peripheral Arterial Disease (PAD) Therapeutics Business (2017-2022)
11.7.5 Symic Bio, Inc. (US) Recent Developments
11.8 TheraVasc Inc. (US)
11.8.1 TheraVasc Inc. (US) Company Details
11.8.2 TheraVasc Inc. (US) Business Overview
11.8.3 TheraVasc Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Introduction
11.8.4 TheraVasc Inc. (US) Revenue in Peripheral Arterial Disease (PAD) Therapeutics Business (2017-2022)
11.8.5 TheraVasc Inc. (US) Recent Developments
11.9 AnGes MG, Inc. (Japan)
11.9.1 AnGes MG, Inc. (Japan) Company Details
11.9.2 AnGes MG, Inc. (Japan) Business Overview
11.9.3 AnGes MG, Inc. (Japan) Peripheral Arterial Disease (PAD) Therapeutics Introduction
11.9.4 AnGes MG, Inc. (Japan) Revenue in Peripheral Arterial Disease (PAD) Therapeutics Business (2017-2022)
11.9.5 AnGes MG, Inc. (Japan) Recent Developments
11.10 Athersys, Inc. (US)
11.10.1 Athersys, Inc. (US) Company Details
11.10.2 Athersys, Inc. (US) Business Overview
11.10.3 Athersys, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Introduction
11.10.4 Athersys, Inc. (US) Revenue in Peripheral Arterial Disease (PAD) Therapeutics Business (2017-2022)
11.10.5 Athersys, Inc. (US) Recent Developments
11.11 Betagenon AB (Sweden)
11.11.1 Betagenon AB (Sweden) Company Details
11.11.2 Betagenon AB (Sweden) Business Overview
11.11.3 Betagenon AB (Sweden) Peripheral Arterial Disease (PAD) Therapeutics Introduction
11.11.4 Betagenon AB (Sweden) Revenue in Peripheral Arterial Disease (PAD) Therapeutics Business (2017-2022)
11.11.5 Betagenon AB (Sweden) Recent Developments
11.12 miRagen Therapeutics, Inc. (US)
11.12.1 miRagen Therapeutics, Inc. (US) Company Details
11.12.2 miRagen Therapeutics, Inc. (US) Business Overview
11.12.3 miRagen Therapeutics, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Introduction
11.12.4 miRagen Therapeutics, Inc. (US) Revenue in Peripheral Arterial Disease (PAD) Therapeutics Business (2017-2022)
11.12.5 miRagen Therapeutics, Inc. (US) Recent Developments
11.13 Multi Gene Vascular Systems Ltd (Israel)
11.13.1 Multi Gene Vascular Systems Ltd (Israel) Company Details
11.13.2 Multi Gene Vascular Systems Ltd (Israel) Business Overview
11.13.3 Multi Gene Vascular Systems Ltd (Israel) Peripheral Arterial Disease (PAD) Therapeutics Introduction
11.13.4 Multi Gene Vascular Systems Ltd (Israel) Revenue in Peripheral Arterial Disease (PAD) Therapeutics Business (2017-2022)
11.13.5 Multi Gene Vascular Systems Ltd (Israel) Recent Developments
11.14 ViroMed Co. Ltd. (Korea)
11.14.1 ViroMed Co. Ltd. (Korea) Company Details
11.14.2 ViroMed Co. Ltd. (Korea) Business Overview
11.14.3 ViroMed Co. Ltd. (Korea) Peripheral Arterial Disease (PAD) Therapeutics Introduction
11.14.4 ViroMed Co. Ltd. (Korea) Revenue in Peripheral Arterial Disease (PAD) Therapeutics Business (2017-2022)
11.14.5 ViroMed Co. Ltd. (Korea) Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer